Dulaglutide
compound
preliminary evidencePublic
Once-weekly GLP-1 RA with IgG4-Fc fusion for extended half-life. FDA-approved for T2D and cardiovascular risk reduction. Brand name: Trulicity.
Category: Metabolic Glp1·Updated 5/19/2026
Dulaglutide
Once-weekly GLP-1 RA with IgG4-Fc fusion for extended half-life. FDA-approved for T2D and cardiovascular risk reduction. Brand name: Trulicity.